| Code | Description | Claims | Beneficiaries | Total Paid |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
909,870 |
749,869 |
$72.29M |
| G9001 |
Coordinated care fee, initial rate |
91,583 |
91,079 |
$31.64M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
115,115 |
107,233 |
$16.57M |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
2,843 |
2,767 |
$12.10M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
40,547 |
37,204 |
$10.53M |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
91,152 |
89,785 |
$10.52M |
| G0378 |
Hospital observation service, per hour |
24,139 |
21,969 |
$10.20M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
49,773 |
45,750 |
$8.70M |
| A0430 |
Ambulance service, conventional air services, transport, one way (fixed wing) |
3,243 |
3,036 |
$6.53M |
| J1745 |
Injection, infliximab, excludes biosimilar, 10 mg |
2,076 |
1,577 |
$6.41M |
| J9271 |
Injection, pembrolizumab, 1 mg |
817 |
620 |
$6.40M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
22,123 |
21,162 |
$5.81M |
| 70450 |
Computed tomography, head or brain; without contrast material |
26,872 |
24,922 |
$5.17M |
| A0435 |
Fixed wing air mileage, per statute mile |
3,242 |
3,034 |
$5.03M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
80,634 |
75,161 |
$4.10M |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
70,277 |
60,709 |
$4.04M |
| J9312 |
Injection, rituximab, 10 mg |
784 |
507 |
$3.90M |
| 80048 |
Basic metabolic panel (calcium, ionized) |
229,644 |
186,092 |
$3.48M |
| H2017 |
Psychosocial rehabilitation services, per 15 minutes |
35,903 |
3,690 |
$3.40M |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
5,747 |
3,614 |
$3.28M |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
75,741 |
53,318 |
$3.05M |
| 93303 |
Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study |
5,751 |
5,564 |
$3.04M |
| H0039 |
Assertive community treatment, face-to-face, per 15 minutes |
18,439 |
2,082 |
$3.00M |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
11,516 |
11,245 |
$3.00M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
54,957 |
28,105 |
$2.86M |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
7,024 |
6,816 |
$2.85M |
| H2033 |
Multisystemic therapy for juveniles, per 15 minutes |
10,555 |
1,332 |
$2.76M |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
6,135 |
6,036 |
$2.70M |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
30,150 |
14,922 |
$2.42M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
26,574 |
25,631 |
$2.31M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
57,867 |
54,235 |
$2.22M |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
18,781 |
12,005 |
$2.21M |
| 71046 |
Radiologic examination, chest; 2 views |
44,240 |
41,280 |
$2.19M |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
26,777 |
25,335 |
$2.17M |
| 72125 |
Computed tomography, cervical spine; without contrast material |
8,787 |
8,417 |
$2.05M |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
5,458 |
5,257 |
$1.90M |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
40,154 |
38,261 |
$1.87M |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
18,224 |
17,016 |
$1.86M |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
5,572 |
5,444 |
$1.83M |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
4,468 |
4,338 |
$1.78M |
| G0390 |
Trauma response team associated with hospital critical care service |
1,189 |
1,152 |
$1.77M |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
1,154 |
1,143 |
$1.73M |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
21,203 |
20,393 |
$1.72M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
41,522 |
37,302 |
$1.71M |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
139,585 |
114,808 |
$1.70M |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
12,582 |
12,347 |
$1.63M |
| J7307 |
Etonogestrel (contraceptive) implant system, including implant and supplies |
1,716 |
1,555 |
$1.62M |
| 90837 |
Psychotherapy, 53 minutes with patient |
17,241 |
10,619 |
$1.62M |
| 77386 |
|
3,746 |
374 |
$1.57M |
| 80076 |
|
118,249 |
104,431 |
$1.55M |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
40,183 |
38,283 |
$1.55M |
| 96375 |
Therapeutic injection; each additional sequential IV push |
36,059 |
27,349 |
$1.54M |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
9,396 |
6,422 |
$1.52M |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
4,104 |
3,955 |
$1.51M |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
17,715 |
14,318 |
$1.50M |
| 70498 |
|
4,740 |
4,557 |
$1.49M |
| J2505 |
Injection, pegfilgrastim, 6 mg |
484 |
380 |
$1.43M |
| 92587 |
|
12,518 |
12,298 |
$1.43M |
| J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) |
921 |
537 |
$1.42M |
| H2015 |
Comprehensive community support services, per 15 minutes |
12,149 |
5,022 |
$1.39M |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
37,802 |
37,063 |
$1.38M |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
2,821 |
2,612 |
$1.36M |
| J1569 |
Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg |
591 |
358 |
$1.33M |
| 84443 |
Thyroid stimulating hormone (TSH) |
55,156 |
53,403 |
$1.33M |
| 76770 |
|
12,133 |
11,985 |
$1.31M |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
1,940 |
1,905 |
$1.30M |
| 76819 |
Fetal biophysical profile; without non-stress testing |
10,702 |
5,461 |
$1.26M |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
48,067 |
38,707 |
$1.24M |
| 99215 |
Prolong outpt/office vis |
16,481 |
15,598 |
$1.24M |
| 73610 |
|
13,383 |
11,588 |
$1.22M |
| 73130 |
|
18,138 |
14,835 |
$1.20M |
| C8929 |
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography |
3,191 |
3,127 |
$1.19M |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
24,389 |
23,035 |
$1.18M |
| Q3014 |
Telehealth originating site facility fee |
30,532 |
27,704 |
$1.17M |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
2,849 |
2,772 |
$1.17M |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
769 |
762 |
$1.16M |
| 85027 |
|
135,027 |
114,950 |
$1.16M |
| 73562 |
|
12,739 |
11,359 |
$1.09M |
| A0431 |
Ambulance service, conventional air services, transport, one way (rotary wing) |
482 |
450 |
$1.06M |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
16,962 |
14,490 |
$1.03M |
| 93976 |
|
8,877 |
8,587 |
$1.01M |
| J9299 |
Injection, nivolumab, 1 mg |
132 |
102 |
$992K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
2,891 |
2,717 |
$981K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
42,669 |
39,967 |
$976K |
| 73630 |
|
14,826 |
12,621 |
$976K |
| T1007 |
Alcohol and/or substance abuse services, treatment plan development and/or modification |
7,446 |
7,030 |
$960K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
3,279 |
3,230 |
$948K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
5,205 |
5,160 |
$945K |
| 20610 |
|
9,642 |
7,573 |
$938K |
| 73110 |
|
13,571 |
11,366 |
$934K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
67,914 |
66,229 |
$932K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
18,899 |
15,717 |
$917K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
1,541 |
1,404 |
$894K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
17,060 |
8,096 |
$887K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
1,149 |
1,136 |
$886K |
| 59025 |
Fetal non-stress test |
7,882 |
5,347 |
$861K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
19,135 |
18,537 |
$854K |
| 72170 |
|
9,549 |
9,319 |
$854K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
43,513 |
42,996 |
$850K |
| 94010 |
|
6,418 |
6,281 |
$847K |
| 97597 |
|
12,558 |
5,441 |
$827K |
| 86003 |
|
1,730 |
1,681 |
$812K |
| 71045 |
Radiologic examination, chest; single view |
18,287 |
16,591 |
$809K |
| 73030 |
|
10,113 |
9,037 |
$800K |
| J7298 |
Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg |
824 |
760 |
$800K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
24,113 |
23,944 |
$782K |
| 74183 |
|
2,016 |
1,996 |
$771K |
| J1561 |
Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg |
354 |
226 |
$763K |
| 81513 |
|
7,478 |
7,151 |
$757K |
| 93325 |
|
8,543 |
8,253 |
$752K |
| 20553 |
|
5,536 |
4,874 |
$746K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
2,245 |
2,196 |
$744K |
| 90870 |
|
1,943 |
680 |
$742K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
49,556 |
45,796 |
$736K |
| 0225U |
|
3,635 |
3,555 |
$735K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
6,090 |
5,932 |
$729K |
| 20680 |
|
460 |
447 |
$715K |
| 72082 |
|
5,905 |
5,843 |
$711K |
| J9310 |
Injection, rituximab, 100 mg |
160 |
125 |
$699K |
| 43235 |
|
1,625 |
1,575 |
$694K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
12,539 |
12,317 |
$691K |
| 72141 |
|
2,229 |
2,211 |
$675K |
| J7323 |
Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose |
3,379 |
1,753 |
$671K |
| 95811 |
|
1,027 |
1,020 |
$670K |
| 73080 |
|
9,156 |
8,048 |
$670K |
| 73590 |
|
10,009 |
8,813 |
$666K |
| 80061 |
Lipid panel |
42,845 |
41,888 |
$658K |
| J0897 |
Injection, denosumab, 1 mg |
998 |
965 |
$653K |
| 70486 |
|
3,139 |
3,040 |
$645K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
8,573 |
7,620 |
$639K |
| 70496 |
|
2,348 |
2,229 |
$639K |
| 92557 |
|
5,825 |
5,718 |
$630K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
5,764 |
5,738 |
$630K |
| A0436 |
Rotary wing air mileage, per statute mile |
482 |
450 |
$630K |
| 84702 |
|
28,913 |
25,663 |
$629K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
9,475 |
8,058 |
$628K |
| J0178 |
Injection, aflibercept, 1 mg |
495 |
482 |
$623K |
| 83735 |
|
76,262 |
60,777 |
$622K |
| 87536 |
|
7,051 |
6,910 |
$615K |
| 73090 |
|
8,263 |
7,221 |
$608K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
6,151 |
5,975 |
$608K |
| J3490 |
Unclassified drugs |
43,115 |
30,646 |
$604K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
5,092 |
4,900 |
$597K |
| 76801 |
|
5,857 |
5,381 |
$589K |
| 74018 |
|
8,576 |
7,943 |
$578K |
| 92567 |
|
12,901 |
12,730 |
$576K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
5,810 |
5,688 |
$558K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
2,955 |
2,859 |
$553K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
7,802 |
3,884 |
$547K |
| 71250 |
|
4,094 |
4,008 |
$537K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
10,250 |
10,095 |
$527K |
| 93975 |
|
3,713 |
3,638 |
$523K |
| 84484 |
|
34,902 |
23,262 |
$518K |
| 36415 |
Collection of venous blood by venipuncture |
65,241 |
60,812 |
$514K |
| 86850 |
|
25,894 |
23,043 |
$499K |
| 20552 |
|
3,725 |
3,451 |
$497K |
| 36430 |
|
2,430 |
1,605 |
$490K |
| C8930 |
Transthoracic echocardiography, with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report; including performance of continuous electrocardiographic monitoring, with physician supervision |
1,357 |
1,340 |
$488K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
5,675 |
5,618 |
$480K |
| 73564 |
|
4,415 |
4,118 |
$471K |
| 73221 |
|
1,525 |
1,444 |
$467K |
| 76830 |
Ultrasound, transvaginal |
5,186 |
5,035 |
$459K |
| 84100 |
|
81,913 |
66,309 |
$455K |
| 81001 |
|
80,304 |
73,932 |
$454K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
11,147 |
7,264 |
$440K |
| 90832 |
Psychotherapy, 30 minutes with patient |
8,064 |
6,696 |
$436K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
5,962 |
5,822 |
$429K |
| 72100 |
|
5,283 |
5,102 |
$427K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
9,728 |
9,280 |
$427K |
| 96376 |
|
13,236 |
9,744 |
$425K |
| 76825 |
|
810 |
762 |
$423K |
| 76000 |
|
2,977 |
2,872 |
$421K |
| 80053 |
Comprehensive metabolic panel |
51,696 |
44,420 |
$419K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
7,306 |
5,578 |
$419K |
| 86780 |
|
20,482 |
19,958 |
$413K |
| 87481 |
|
10,424 |
9,928 |
$405K |
| 97542 |
|
2,497 |
2,443 |
$404K |
| 96416 |
|
2,403 |
1,342 |
$398K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
964 |
941 |
$398K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
4,054 |
3,888 |
$394K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
4,736 |
4,082 |
$393K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
6,777 |
6,535 |
$384K |
| 72110 |
|
4,169 |
4,090 |
$383K |
| 96415 |
|
6,047 |
4,407 |
$383K |
| 93320 |
|
5,598 |
5,413 |
$382K |
| 97602 |
|
6,509 |
3,417 |
$381K |
| 93971 |
|
4,165 |
3,995 |
$381K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
14,614 |
14,055 |
$379K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
976 |
950 |
$376K |
| 96417 |
|
4,190 |
2,853 |
$376K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
4,254 |
4,074 |
$371K |
| 83880 |
|
13,639 |
12,169 |
$370K |
| 92579 |
|
3,335 |
3,320 |
$368K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
5,404 |
4,734 |
$364K |
| 82077 |
|
12,385 |
11,336 |
$363K |
| 72197 |
|
811 |
798 |
$363K |
| 83690 |
|
41,716 |
38,166 |
$362K |
| 87040 |
|
11,147 |
8,327 |
$360K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
13,319 |
12,497 |
$359K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
4,043 |
3,927 |
$358K |
| 70491 |
|
1,394 |
1,362 |
$357K |
| 54161 |
|
246 |
245 |
$357K |
| 29075 |
|
2,248 |
2,159 |
$354K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
2,905 |
2,754 |
$353K |
| 73552 |
|
5,194 |
4,708 |
$344K |
| 84439 |
|
28,235 |
27,295 |
$343K |
| 51102 |
|
457 |
366 |
$341K |
| 77073 |
|
2,949 |
2,924 |
$337K |
| 90847 |
Family psychotherapy with the patient present, 50 minutes |
2,153 |
1,423 |
$335K |
| 96367 |
|
6,458 |
4,767 |
$335K |
| 83970 |
|
8,120 |
7,725 |
$333K |
| 90834 |
Psychotherapy, 45 minutes with patient |
4,225 |
2,992 |
$332K |
| 83655 |
|
7,565 |
7,428 |
$329K |
| 90461 |
|
7,900 |
7,867 |
$323K |
| 44970 |
|
110 |
104 |
$318K |
| 90791 |
Psychiatric diagnostic evaluation |
3,196 |
3,038 |
$318K |
| 80074 |
|
4,761 |
4,666 |
$314K |
| 29405 |
|
1,751 |
1,480 |
$312K |
| 67028 |
Intravitreal injection of a pharmacologic agent |
1,834 |
1,777 |
$311K |
| 82728 |
|
18,652 |
18,007 |
$310K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
7,487 |
4,788 |
$310K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
1,215 |
973 |
$310K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
10,694 |
10,183 |
$309K |
| 76642 |
|
3,125 |
3,084 |
$307K |
| 77336 |
|
2,923 |
1,433 |
$298K |
| 86803 |
|
14,733 |
14,476 |
$297K |
| 93970 |
|
2,331 |
2,281 |
$296K |
| 29581 |
|
5,684 |
1,737 |
$294K |
| 90715 |
|
13,900 |
13,645 |
$288K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
2,770 |
2,742 |
$287K |
| 72146 |
|
897 |
883 |
$287K |
| 76536 |
|
3,098 |
3,058 |
$285K |
| Q9957 |
Injection, perflutren lipid microspheres, per ml |
3,455 |
3,387 |
$282K |
| 73060 |
|
4,431 |
4,073 |
$279K |
| 86480 |
|
5,650 |
5,546 |
$278K |
| 88307 |
|
2,172 |
2,108 |
$277K |
| 74181 |
|
795 |
786 |
$276K |
| 36591 |
|
7,694 |
6,120 |
$276K |
| 73502 |
|
4,909 |
4,731 |
$274K |
| 96127 |
|
6,859 |
6,700 |
$274K |
| C1769 |
Guide wire |
5,220 |
4,658 |
$274K |
| 97535 |
Self-care/home management training, each 15 minutes |
9,794 |
7,582 |
$273K |
| 82803 |
|
10,170 |
9,633 |
$273K |
| 72072 |
|
3,398 |
3,293 |
$270K |
| 94060 |
|
2,409 |
2,369 |
$268K |
| 87077 |
|
20,459 |
19,235 |
$266K |
| 92134 |
|
8,738 |
8,263 |
$265K |
| 92526 |
|
3,281 |
1,988 |
$264K |
| 99173 |
|
3,932 |
3,882 |
$264K |
| 87522 |
Neg quan hep c or qual rna |
4,298 |
4,184 |
$263K |
| 86160 |
|
6,286 |
5,850 |
$263K |
| 81025 |
|
18,165 |
17,326 |
$260K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
12,084 |
12,017 |
$252K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,894 |
2,847 |
$252K |
| 74178 |
|
1,104 |
1,083 |
$252K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
6,619 |
6,479 |
$251K |
| G0009 |
Administration of pneumococcal vaccine |
13,351 |
13,246 |
$251K |
| 86235 |
|
3,126 |
3,028 |
$250K |
| 86140 |
|
38,874 |
35,332 |
$249K |
| 72050 |
|
2,628 |
2,595 |
$248K |
| G0384 |
Level 5 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) |
1,165 |
1,141 |
$248K |
| 82570 |
|
35,861 |
32,844 |
$244K |
| 72158 |
|
551 |
538 |
$244K |
| 99172 |
|
1,845 |
1,804 |
$243K |
| 77334 |
|
1,021 |
779 |
$241K |
| 64615 |
|
2,049 |
1,941 |
$237K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
3,980 |
3,963 |
$236K |
| 83605 |
|
16,327 |
13,711 |
$228K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
4,823 |
4,666 |
$226K |
| 88185 |
|
853 |
752 |
$225K |
| 88342 |
|
5,124 |
4,914 |
$225K |
| 76870 |
|
1,870 |
1,806 |
$224K |
| 94760 |
|
14,481 |
13,758 |
$224K |
| 85610 |
|
49,515 |
42,005 |
$223K |
| 72156 |
|
502 |
493 |
$221K |
| J2704 |
Injection, propofol, 10 mg |
22,117 |
20,916 |
$220K |
| 95812 |
|
1,247 |
1,232 |
$212K |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
2,303 |
2,265 |
$211K |
| 58300 |
|
1,262 |
1,232 |
$211K |
| 97760 |
|
3,994 |
3,236 |
$207K |
| 67311 |
|
110 |
110 |
$206K |
| 69210 |
|
2,299 |
2,247 |
$205K |
| 52000 |
|
575 |
567 |
$202K |
| 76820 |
|
2,784 |
1,361 |
$202K |
| 87186 |
|
15,918 |
15,038 |
$202K |
| 87653 |
|
4,261 |
4,155 |
$201K |
| 29065 |
|
1,153 |
1,123 |
$198K |
| 97163 |
|
2,698 |
2,666 |
$197K |
| 43264 |
|
271 |
263 |
$194K |
| 99442 |
|
3,665 |
3,474 |
$194K |
| 84403 |
|
6,488 |
6,279 |
$193K |
| 17110 |
|
1,926 |
1,852 |
$190K |
| C1889 |
Implantable/insertable device, not otherwise classified |
1,103 |
1,043 |
$189K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
54,967 |
44,973 |
$188K |
| 72195 |
|
469 |
463 |
$187K |
| 80305 |
|
17,008 |
15,817 |
$187K |
| 76813 |
|
2,933 |
2,898 |
$186K |
| 93226 |
|
1,638 |
1,619 |
$183K |
| 36592 |
|
5,768 |
4,201 |
$183K |
| J9355 |
Injection, trastuzumab, excludes biosimilar, 10 mg |
94 |
38 |
$183K |
| 97161 |
|
8,097 |
7,908 |
$178K |
| 96116 |
|
1,036 |
1,019 |
$175K |
| 94660 |
|
2,244 |
2,027 |
$175K |
| 81514 |
|
1,593 |
1,542 |
$174K |
| 92083 |
|
3,371 |
3,273 |
$174K |
| 94729 |
|
2,554 |
2,520 |
$171K |
| 92610 |
|
2,102 |
2,045 |
$170K |
| 92133 |
|
4,603 |
4,505 |
$170K |
| 97162 |
|
4,441 |
4,332 |
$169K |
| 86147 |
|
1,561 |
1,532 |
$166K |
| 86361 |
|
5,817 |
5,742 |
$164K |
| 82607 |
|
9,896 |
9,731 |
$164K |
| A9577 |
Injection, gadobenate dimeglumine (multihance), per ml |
7,268 |
7,118 |
$163K |
| 31231 |
|
1,197 |
1,183 |
$163K |
| 93017 |
|
934 |
908 |
$162K |
| 64721 |
|
184 |
174 |
$160K |
| 77080 |
|
2,653 |
2,620 |
$160K |
| 82785 |
|
2,620 |
2,549 |
$159K |
| 77066 |
Tomosynthesis, mammo |
1,852 |
1,834 |
$159K |
| G0500 |
Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) |
8,543 |
8,090 |
$159K |
| 74230 |
|
1,857 |
1,836 |
$158K |
| P9047 |
Infusion, albumin (human), 25%, 50 ml |
941 |
444 |
$157K |
| G0475 |
Hiv antigen/antibody, combination assay, screening |
18,776 |
18,384 |
$156K |
| L1960 |
Ankle foot orthosis, posterior solid ankle, plastic, custom fabricated |
317 |
195 |
$155K |
| 31575 |
|
1,121 |
1,097 |
$155K |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
16,068 |
13,669 |
$154K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
15,670 |
15,123 |
$153K |
| 82043 |
|
14,852 |
14,514 |
$153K |
| 94726 |
|
1,375 |
1,355 |
$153K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
3,670 |
3,599 |
$152K |
| 96409 |
|
1,610 |
1,057 |
$151K |
| 51798 |
|
3,962 |
3,841 |
$151K |
| G0145 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
6,292 |
6,173 |
$151K |
| 83520 |
|
5,272 |
4,099 |
$151K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
47,157 |
43,828 |
$148K |
| 83550 |
|
14,824 |
14,449 |
$148K |
| 11102 |
|
1,071 |
1,053 |
$145K |
| 36416 |
|
13,740 |
12,487 |
$144K |
| 87340 |
|
10,077 |
9,804 |
$143K |
| 49083 |
|
696 |
314 |
$142K |
| 12001 |
|
1,393 |
1,366 |
$140K |
| 77412 |
|
1,342 |
163 |
$140K |
| 77301 |
|
157 |
147 |
$138K |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
2,606 |
2,459 |
$138K |
| 86923 |
|
2,181 |
1,823 |
$137K |
| C8908 |
Magnetic resonance imaging without contrast followed by with contrast, breast; bilateral |
352 |
352 |
$137K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
30,012 |
27,011 |
$137K |
| 82784 |
|
8,528 |
8,207 |
$135K |
| 99153 |
Mod sedat endo service >5yrs |
7,637 |
7,378 |
$134K |
| 96900 |
|
4,643 |
923 |
$134K |
| 47562 |
|
56 |
54 |
$134K |
| 51701 |
|
1,732 |
1,655 |
$133K |
| J9035 |
Injection, bevacizumab, 10 mg |
58 |
26 |
$131K |
| 80143 |
|
6,105 |
5,552 |
$130K |
| 77065 |
Tomosynthesis, mammo |
1,860 |
1,763 |
$129K |
| 12002 |
|
1,284 |
1,254 |
$129K |
| 80179 |
|
6,013 |
5,468 |
$127K |
| 83540 |
|
16,376 |
15,948 |
$127K |
| 99205 |
Prolong outpt/office vis |
980 |
972 |
$126K |
| 11981 |
|
687 |
679 |
$125K |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
4,297 |
3,781 |
$125K |
| 97116 |
|
3,898 |
2,904 |
$124K |
| 82670 |
|
3,821 |
3,754 |
$124K |
| 94761 |
|
4,455 |
3,419 |
$123K |
| 86900 |
|
28,032 |
23,541 |
$123K |
| 92555 |
|
1,152 |
1,135 |
$123K |
| 12011 |
|
1,141 |
1,112 |
$121K |
| 43259 |
|
288 |
274 |
$120K |
| 85730 |
|
16,556 |
15,685 |
$120K |
| 92611 |
|
1,501 |
1,486 |
$120K |
| 87480 |
|
4,701 |
4,507 |
$119K |
| 87510 |
|
4,702 |
4,508 |
$119K |
| 87660 |
|
4,702 |
4,508 |
$119K |
| 72040 |
|
1,332 |
1,278 |
$118K |
| 88304 |
|
3,886 |
3,764 |
$118K |
| 86901 |
|
28,073 |
23,566 |
$118K |
| 76886 |
|
1,099 |
1,043 |
$116K |
| 93923 |
|
1,549 |
1,515 |
$114K |
| H2010 |
Comprehensive medication services, per 15 minutes |
861 |
498 |
$114K |
| 83516 |
|
5,131 |
4,548 |
$114K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,818 |
1,755 |
$114K |
| 85652 |
|
31,611 |
28,912 |
$114K |
| J2997 |
Injection, alteplase recombinant, 1 mg |
645 |
570 |
$113K |
| G0008 |
Administration of influenza virus vaccine |
14,366 |
14,305 |
$112K |
| 84156 |
|
23,163 |
21,097 |
$111K |
| 90670 |
|
10,775 |
10,709 |
$111K |
| 90474 |
|
5,178 |
5,141 |
$110K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,269 |
1,232 |
$110K |
| 72190 |
|
1,108 |
1,056 |
$109K |
| 58301 |
|
458 |
447 |
$109K |
| 96161 |
|
2,858 |
2,829 |
$109K |
| 73000 |
|
1,550 |
1,438 |
$107K |
| J7050 |
Infusion, normal saline solution, 250 cc |
10,964 |
7,866 |
$107K |
| J2560 |
Injection, phenobarbital sodium, up to 120 mg |
2,800 |
2,021 |
$107K |
| J1439 |
Injection, ferric carboxymaltose, 1 mg |
178 |
111 |
$106K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
1,616 |
1,585 |
$106K |
| 72157 |
|
243 |
237 |
$106K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
5,348 |
5,263 |
$105K |
| 82805 |
|
2,544 |
1,898 |
$104K |
| 99080 |
|
27,972 |
27,718 |
$104K |
| 64642 |
|
415 |
408 |
$103K |
| 86038 |
|
6,828 |
6,689 |
$102K |
| C1773 |
Retrieval device, insertable (used to retrieve fractured medical devices) |
2,835 |
2,774 |
$102K |
| 82378 |
|
4,263 |
3,565 |
$101K |
| 77300 |
|
437 |
400 |
$100K |
| 88312 |
|
1,642 |
1,597 |
$100K |
| 87632 |
|
432 |
425 |
$99K |
| 74174 |
|
305 |
296 |
$99K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
8,519 |
8,255 |
$99K |
| 92558 |
|
1,801 |
1,793 |
$99K |
| 95700 |
|
503 |
487 |
$97K |
| 87799 |
|
2,453 |
2,220 |
$96K |
| 69209 |
|
1,469 |
1,402 |
$96K |
| 97113 |
|
630 |
326 |
$95K |
| 96119 |
|
230 |
230 |
$94K |
| 90732 |
|
1,246 |
1,207 |
$94K |
| 83615 |
|
10,784 |
9,297 |
$93K |
| 90651 |
|
4,322 |
4,289 |
$92K |
| J1453 |
Injection, fosaprepitant, 1 mg |
758 |
542 |
$92K |
| J9070 |
Cyclophosphamide, 100 mg |
186 |
111 |
$92K |
| J8501 |
Aprepitant, oral, 5 mg |
936 |
663 |
$92K |
| 10060 |
|
983 |
940 |
$92K |
| 25600 |
|
564 |
553 |
$91K |
| 97802 |
|
1,540 |
1,529 |
$90K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
7,661 |
5,984 |
$90K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
34,037 |
28,904 |
$89K |
| 87070 |
|
5,716 |
5,421 |
$89K |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
1,126 |
1,071 |
$89K |
| G0382 |
Level 3 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) |
925 |
903 |
$89K |
| 54640 |
|
39 |
39 |
$88K |
| 81002 |
|
13,631 |
12,563 |
$88K |
| 97803 |
|
2,131 |
2,066 |
$88K |
| 86225 |
|
5,034 |
4,772 |
$87K |
| J2426 |
Injection, paliperidone palmitate extended release (invega sustenna), 1 mg |
16 |
15 |
$86K |
| 36000 |
|
5,941 |
5,766 |
$86K |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
2,114 |
2,070 |
$86K |
| 99152 |
|
3,905 |
3,699 |
$86K |
| 95886 |
|
1,124 |
1,106 |
$86K |
| 82550 |
|
9,921 |
9,021 |
$86K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
1,678 |
1,602 |
$85K |
| 88313 |
|
1,555 |
1,495 |
$85K |
| 82248 |
|
8,481 |
6,708 |
$85K |
| 87902 |
|
275 |
275 |
$85K |
| 82105 |
|
4,124 |
3,907 |
$85K |
| 97167 |
|
996 |
984 |
$83K |
| 80197 |
|
6,160 |
4,201 |
$82K |
| 96401 |
|
2,076 |
1,170 |
$82K |
| 96523 |
|
2,174 |
1,825 |
$82K |
| 99443 |
|
1,192 |
1,129 |
$82K |
| 95713 |
|
212 |
203 |
$82K |
| 97165 |
|
3,437 |
3,377 |
$82K |
| 96411 |
|
1,622 |
1,128 |
$81K |
| 99606 |
|
3,237 |
2,847 |
$80K |
| 95782 |
|
86 |
85 |
$80K |
| 92652 |
|
316 |
307 |
$79K |
| 82565 |
|
14,351 |
13,730 |
$79K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
447 |
392 |
$78K |
| 84480 |
|
4,423 |
4,135 |
$78K |
| 72081 |
|
934 |
917 |
$78K |
| 92582 |
|
612 |
600 |
$78K |
| 73560 |
|
1,182 |
1,073 |
$77K |
| 84460 |
|
9,720 |
9,429 |
$77K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
15,087 |
13,623 |
$77K |
| G0010 |
Administration of hepatitis b vaccine |
3,792 |
3,761 |
$77K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
2,895 |
2,815 |
$76K |
| 84270 |
|
4,368 |
4,230 |
$76K |
| J1631 |
Injection, haloperidol decanoate, per 50 mg |
1,183 |
1,049 |
$76K |
| 73523 |
|
591 |
584 |
$76K |
| 96118 |
|
237 |
237 |
$76K |
| 82746 |
|
4,662 |
4,595 |
$76K |
| 64483 |
|
224 |
222 |
$75K |
| Q9950 |
Injection, sulfur hexafluoride lipid microspheres, per ml |
890 |
866 |
$74K |
| 86762 |
|
5,083 |
4,925 |
$74K |
| J0475 |
Injection, baclofen, 10 mg |
285 |
275 |
$74K |
| 86146 |
|
1,526 |
1,500 |
$73K |
| 85384 |
|
6,438 |
5,924 |
$73K |
| 70543 |
|
153 |
152 |
$73K |
| 87650 |
|
1,623 |
1,606 |
$73K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
7,476 |
4,791 |
$72K |
| 82140 |
|
4,082 |
3,801 |
$72K |
| 84450 |
|
9,418 |
9,142 |
$72K |
| 43244 |
|
164 |
160 |
$71K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
35,085 |
33,095 |
$71K |
| 86787 |
|
5,503 |
5,339 |
$71K |
| 94618 |
|
803 |
781 |
$70K |
| 73140 |
|
1,003 |
956 |
$70K |
| 93225 |
|
1,345 |
1,328 |
$69K |
| 11976 |
|
162 |
158 |
$69K |
| 84153 |
|
3,632 |
3,519 |
$68K |
| 76942 |
|
941 |
916 |
$67K |
| 85379 |
|
4,756 |
4,432 |
$67K |
| 86706 |
|
4,856 |
4,766 |
$66K |
| 11900 |
|
641 |
619 |
$66K |
| 78816 |
|
70 |
68 |
$65K |
| J1815 |
Injection, insulin, per 5 units |
3,343 |
1,970 |
$64K |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
4,645 |
4,569 |
$64K |
| 96450 |
|
265 |
202 |
$63K |
| 76827 |
|
534 |
506 |
$62K |
| 70355 |
|
1,523 |
1,472 |
$62K |
| 73700 |
|
301 |
280 |
$62K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
707 |
617 |
$62K |
| 76882 |
|
648 |
604 |
$60K |
| 83001 |
|
2,374 |
2,328 |
$59K |
| J3380 |
Injection, vedolizumab, intravenous, 1 mg |
15 |
12 |
$59K |
| 11104 |
|
418 |
407 |
$58K |
| 86945 |
|
589 |
379 |
$58K |
| 70360 |
|
909 |
871 |
$58K |
| 84146 |
|
2,203 |
2,151 |
$58K |
| 11100 |
|
546 |
535 |
$57K |
| H2011 |
Crisis intervention service, per 15 minutes |
2,094 |
1,960 |
$56K |
| 93246 |
|
1,132 |
1,116 |
$56K |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
1,941 |
1,902 |
$56K |
| 82247 |
|
4,000 |
2,609 |
$56K |
| 70487 |
|
198 |
191 |
$55K |
| J9190 |
Injection, fluorouracil, 500 mg |
1,971 |
1,149 |
$55K |
| 85018 |
|
8,598 |
8,392 |
$53K |
| 86800 |
|
2,433 |
2,305 |
$53K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,939 |
2,881 |
$53K |
| 95813 |
|
309 |
298 |
$53K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
349 |
251 |
$53K |
| 86356 |
|
379 |
369 |
$53K |
| 86870 |
|
387 |
361 |
$52K |
| 81420 |
Fetal chromosomal aneuploidy genomic sequence analysis panel |
99 |
95 |
$51K |
| 26055 |
|
70 |
52 |
$51K |
| 86708 |
|
3,308 |
3,248 |
$51K |
| 99496 |
|
674 |
649 |
$51K |
| 51702 |
|
999 |
918 |
$51K |
| 86430 |
|
4,136 |
4,014 |
$50K |
| 82977 |
|
5,116 |
4,623 |
$50K |
| 86334 |
|
1,176 |
1,068 |
$49K |
| 74022 |
|
537 |
522 |
$49K |
| 86376 |
|
2,253 |
2,214 |
$49K |
| 87497 |
|
1,647 |
1,341 |
$49K |
| 86704 |
|
4,109 |
4,022 |
$48K |
| 87338 |
|
2,702 |
2,667 |
$48K |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
3,253 |
2,559 |
$46K |
| J1644 |
Injection, heparin sodium, per 1000 units |
7,673 |
4,159 |
$46K |
| 87505 |
|
1,433 |
1,340 |
$46K |
| 96160 |
|
1,222 |
1,213 |
$45K |
| 95951 |
|
91 |
59 |
$45K |
| 86200 |
|
2,880 |
2,822 |
$45K |
| 87205 |
|
6,720 |
6,293 |
$44K |
| 64493 |
|
102 |
99 |
$44K |
| 94727 |
|
518 |
511 |
$44K |
| 97166 |
|
1,490 |
1,440 |
$44K |
| 86304 |
|
1,529 |
1,405 |
$43K |
| 76937 |
|
728 |
679 |
$42K |
| 93321 |
|
1,827 |
1,797 |
$42K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
7,942 |
3,683 |
$42K |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
2,500 |
2,422 |
$42K |
| 87075 |
|
2,540 |
1,943 |
$42K |
| 86355 |
|
1,231 |
1,159 |
$42K |
| J9263 |
Injection, oxaliplatin, 0.5 mg |
502 |
205 |
$41K |
| 84550 |
|
7,035 |
6,316 |
$41K |
| 77077 |
|
376 |
371 |
$41K |
| 83002 |
|
1,737 |
1,700 |
$41K |
| 94664 |
|
504 |
495 |
$41K |
| 81373 |
|
193 |
193 |
$40K |
| 70544 |
|
123 |
118 |
$40K |
| 87206 |
|
2,944 |
2,377 |
$39K |
| 86255 |
|
2,000 |
1,942 |
$39K |
| 57454 |
|
184 |
182 |
$39K |
| 84481 |
|
1,889 |
1,831 |
$39K |
| Q5119 |
Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg |
41 |
14 |
$39K |
| 85246 |
|
1,124 |
1,018 |
$39K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
10,178 |
5,322 |
$39K |
| 81375 |
|
132 |
131 |
$38K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
1,305 |
1,060 |
$38K |
| 90677 |
|
804 |
794 |
$38K |
| 86359 |
|
589 |
559 |
$38K |
| 77295 |
|
38 |
37 |
$38K |
| 88184 |
|
935 |
805 |
$38K |
| 87529 |
|
598 |
583 |
$38K |
| 96139 |
|
300 |
299 |
$38K |
| 70250 |
|
454 |
421 |
$37K |
| 43762 |
|
184 |
180 |
$37K |
| 58661 |
|
16 |
16 |
$37K |
| C1726 |
Catheter, balloon dilatation, non-vascular |
325 |
298 |
$37K |
| 95251 |
|
1,325 |
1,312 |
$37K |
| 96402 |
|
1,597 |
1,494 |
$37K |
| C9399 |
Unclassified drugs or biologicals |
976 |
943 |
$37K |
| 88112 |
|
1,576 |
1,507 |
$37K |
| 90785 |
|
4,901 |
3,010 |
$36K |
| 84305 |
|
1,143 |
1,058 |
$36K |
| J3370 |
Injection, vancomycin hcl, 500 mg |
2,856 |
2,137 |
$36K |
| 88720 |
|
3,984 |
2,967 |
$36K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
12,213 |
9,761 |
$36K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
3,121 |
2,357 |
$36K |
| 87102 |
|
2,507 |
2,395 |
$35K |
| 77338 |
|
229 |
211 |
$35K |
| 88341 |
|
2,070 |
1,918 |
$35K |
| 92523 |
|
353 |
339 |
$34K |
| L4361 |
Walking boot, pneumatic and/or vacuum, with or without joints, with or without interface material, prefabricated, off-the-shelf |
254 |
243 |
$34K |
| 93880 |
|
349 |
339 |
$34K |
| 85014 |
|
9,789 |
8,496 |
$34K |
| 92250 |
|
557 |
543 |
$34K |
| 20550 |
|
253 |
242 |
$34K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
382 |
378 |
$33K |
| 99177 |
|
2,437 |
2,422 |
$33K |
| 80164 |
|
1,540 |
1,437 |
$33K |
| 84134 |
|
1,910 |
1,767 |
$32K |
| G0328 |
Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous |
1,755 |
1,726 |
$32K |
| 36593 |
|
293 |
264 |
$32K |
| 92585 |
|
132 |
127 |
$32K |
| J0694 |
Injection, cefoxitin sodium, 1 gm |
1,571 |
1,011 |
$32K |
| 95117 |
|
1,185 |
558 |
$32K |
| 81508 |
|
1,168 |
1,130 |
$31K |
| 95956 |
|
58 |
30 |
$31K |
| 87631 |
|
230 |
227 |
$31K |
| 86256 |
|
2,103 |
1,936 |
$31K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
10,676 |
8,720 |
$30K |
| 84165 |
|
2,861 |
2,589 |
$30K |
| 17000 |
|
664 |
650 |
$30K |
| 82330 |
|
1,983 |
1,570 |
$29K |
| 72052 |
|
315 |
306 |
$29K |
| 82610 |
|
2,276 |
2,194 |
$29K |
| 96132 |
|
176 |
172 |
$29K |
| 99495 |
|
509 |
505 |
$29K |
| L2840 |
Addition to lower extremity orthosis, tibial length sock, fracture or equal, each |
429 |
262 |
$28K |
| 67228 |
|
70 |
58 |
$28K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
353 |
323 |
$28K |
| 74019 |
|
255 |
245 |
$27K |
| J3480 |
Injection, potassium chloride, per 2 meq |
3,115 |
2,183 |
$27K |
| J9045 |
Injection, carboplatin, 50 mg |
833 |
589 |
$27K |
| 83993 |
|
1,704 |
1,671 |
$26K |
| 85613 |
|
1,518 |
1,498 |
$26K |
| 77091 |
|
925 |
900 |
$26K |
| 92551 |
|
445 |
443 |
$26K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
6,745 |
5,167 |
$26K |
| 86360 |
|
470 |
452 |
$26K |
| 85049 |
|
4,832 |
4,650 |
$25K |
| 86665 |
|
500 |
449 |
$25K |
| 92552 |
|
227 |
227 |
$25K |
| 82075 |
|
1,016 |
969 |
$25K |
| 25605 |
|
73 |
71 |
$24K |
| 90473 |
|
1,201 |
1,197 |
$24K |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
3,491 |
3,260 |
$24K |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
3,540 |
3,224 |
$24K |
| 86300 |
|
758 |
674 |
$24K |
| 86258 |
|
2,608 |
2,574 |
$24K |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
2,696 |
2,431 |
$24K |
| 84145 |
|
1,498 |
1,169 |
$23K |
| 86039 |
|
1,696 |
1,663 |
$23K |
| 84445 |
|
329 |
326 |
$23K |
| 72070 |
|
288 |
279 |
$23K |
| 77072 |
|
263 |
261 |
$23K |
| 80299 |
|
1,048 |
989 |
$23K |
| 71101 |
|
247 |
236 |
$23K |
| 86364 |
|
2,607 |
2,572 |
$23K |
| 87116 |
|
1,350 |
1,203 |
$22K |
| 80177 |
|
2,035 |
1,929 |
$22K |
| J0640 |
Injection, leucovorin calcium, per 50 mg |
420 |
248 |
$22K |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
2,076 |
1,779 |
$22K |
| 99607 |
|
896 |
733 |
$21K |
| 64450 |
|
49 |
41 |
$21K |
| 90734 |
|
3,107 |
3,094 |
$21K |
| G0121 |
Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk |
41 |
41 |
$21K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,929 |
1,766 |
$21K |
| G2212 |
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99205, 99215, 99483 for office or other outpatient evaluation and management services) (do not report g2212 on the same date of service as 99358, 99359, 99415, 99416). (do not report g2212 for any time unit less than 15 minutes) |
248 |
243 |
$21K |
| J1953 |
Injection, levetiracetam, 10 mg |
1,274 |
1,071 |
$21K |
| 82533 |
|
1,095 |
941 |
$21K |
| 82085 |
|
1,498 |
1,357 |
$20K |
| 88300 |
|
1,731 |
1,713 |
$20K |
| 29125 |
|
165 |
162 |
$20K |
| 89051 |
|
2,019 |
1,367 |
$20K |
| 97763 |
|
313 |
254 |
$20K |
| 92524 |
|
173 |
172 |
$19K |
| 83521 |
|
1,691 |
1,189 |
$19K |
| 82950 |
|
3,974 |
3,927 |
$19K |
| 95115 |
|
772 |
350 |
$19K |
| 20605 |
|
135 |
133 |
$19K |
| 99233 |
Prolong inpt eval add15 m |
307 |
155 |
$19K |
| 20611 |
|
116 |
109 |
$19K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
1,899 |
1,733 |
$19K |
| H0033 |
Oral medication administration, direct observation |
68 |
68 |
$19K |
| J3489 |
Injection, zoledronic acid, 1 mg |
361 |
345 |
$19K |
| 87015 |
|
1,841 |
1,548 |
$19K |
| P9045 |
Infusion, albumin (human), 5%, 250 ml |
88 |
52 |
$18K |
| 64566 |
|
216 |
112 |
$18K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
2,113 |
1,573 |
$18K |
| J9171 |
Injection, docetaxel, 1 mg |
76 |
41 |
$18K |
| 81003 |
|
3,333 |
3,193 |
$18K |
| 82040 |
|
4,009 |
3,738 |
$18K |
| 11721 |
|
511 |
504 |
$18K |
| 80180 |
|
1,848 |
1,560 |
$17K |
| 83721 |
|
1,418 |
1,372 |
$17K |
| J9370 |
Vincristine sulfate, 1 mg |
1,178 |
729 |
$17K |
| 86828 |
|
883 |
842 |
$17K |
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
114 |
113 |
$17K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
2,244 |
1,934 |
$17K |
| 45381 |
|
60 |
56 |
$16K |
| 93798 |
|
455 |
127 |
$16K |
| 93271 |
|
157 |
144 |
$16K |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
3,865 |
3,722 |
$16K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
6,150 |
5,877 |
$16K |
| 43760 |
|
93 |
86 |
$16K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
36 |
36 |
$16K |
| 82951 |
|
1,063 |
1,051 |
$15K |
| 93296 |
|
721 |
711 |
$15K |
| H0020 |
Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) |
3,016 |
101 |
$15K |
| J2060 |
Injection, lorazepam, 2 mg |
6,135 |
5,036 |
$15K |
| J1950 |
Injection, leuprolide acetate (for depot suspension), per 3.75 mg |
13 |
12 |
$15K |
| 74455 |
|
97 |
94 |
$15K |
| 87641 |
|
671 |
553 |
$15K |
| C1874 |
Stent, coated/covered, with delivery system |
27 |
27 |
$15K |
| 82150 |
|
1,565 |
1,481 |
$15K |
| 85048 |
|
4,191 |
4,047 |
$15K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,720 |
1,237 |
$15K |
| 81511 |
|
398 |
389 |
$14K |
| J0295 |
Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm |
748 |
455 |
$14K |
| 90686 |
|
8,420 |
8,387 |
$14K |
| J7300 |
Intrauterine copper contraceptive (paragard) |
13 |
13 |
$14K |
| 74021 |
|
160 |
139 |
$14K |
| 86357 |
|
514 |
495 |
$14K |
| 95991 |
|
181 |
174 |
$13K |
| 93299 |
|
467 |
459 |
$13K |
| 92025 |
|
318 |
313 |
$13K |
| J3411 |
Injection, thiamine hcl, 100 mg |
1,076 |
820 |
$13K |
| 90746 |
|
194 |
190 |
$13K |
| 92081 |
|
287 |
278 |
$13K |
| 93356 |
|
113 |
104 |
$13K |
| 93308 |
|
64 |
60 |
$13K |
| 74241 |
|
115 |
115 |
$12K |
| 92553 |
|
98 |
97 |
$12K |
| 64643 |
|
128 |
123 |
$12K |
| 99406 |
|
744 |
731 |
$12K |
| 17003 |
|
170 |
169 |
$12K |
| J9201 |
Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg |
335 |
142 |
$12K |
| 29515 |
|
140 |
133 |
$12K |
| 95911 |
|
106 |
106 |
$12K |
| 87901 |
|
45 |
44 |
$12K |
| 91320 |
|
314 |
307 |
$12K |
| C9257 |
Injection, bevacizumab, 0.25 mg |
537 |
532 |
$12K |
| 90480 |
|
1,050 |
1,036 |
$11K |
| 64494 |
|
67 |
64 |
$11K |
| 88173 |
|
265 |
240 |
$11K |
| 86592 |
|
1,966 |
1,917 |
$11K |
| 51700 |
|
121 |
94 |
$11K |
| 31579 |
|
50 |
50 |
$11K |
| 99441 |
|
376 |
353 |
$11K |
| 80175 |
|
765 |
737 |
$11K |
| 11982 |
|
40 |
40 |
$11K |
| 87486 |
|
303 |
298 |
$11K |
| 70480 |
|
66 |
64 |
$11K |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
3,162 |
2,630 |
$11K |
| J1790 |
Injection, droperidol, up to 5 mg |
2,384 |
2,175 |
$11K |
| C2617 |
Stent, non-coronary, temporary, without delivery system |
247 |
233 |
$10K |
| 58100 |
|
110 |
108 |
$10K |
| 84466 |
|
744 |
734 |
$10K |
| A0434 |
Specialty care transport (sct) |
81 |
81 |
$10K |
| D1208 |
Topical application of fluoride, excluding varnish |
104 |
103 |
$10K |
| 86301 |
|
453 |
398 |
$10K |
| 43273 |
|
16 |
15 |
$10K |
| 90688 |
|
710 |
705 |
$10K |
| 87581 |
|
305 |
300 |
$10K |
| 84432 |
|
548 |
487 |
$10K |
| 88108 |
|
296 |
242 |
$10K |
| J9267 |
Injection, paclitaxel, 1 mg |
600 |
316 |
$10K |
| 87449 |
|
921 |
897 |
$10K |
| 87324 |
|
571 |
559 |
$10K |
| 52287 |
|
12 |
12 |
$10K |
| 92609 |
|
278 |
146 |
$9K |
| 92504 |
|
649 |
635 |
$9K |
| 95250 |
|
76 |
75 |
$9K |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
2,032 |
1,824 |
$9K |
| A0425 |
Ground mileage, per statute mile |
610 |
598 |
$9K |
| 49082 |
|
37 |
26 |
$9K |
| 84436 |
|
978 |
962 |
$9K |
| 51741 |
|
171 |
168 |
$9K |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
1,147 |
786 |
$9K |
| 82390 |
|
723 |
715 |
$9K |
| C9113 |
Injection, pantoprazole sodium, per vial |
1,739 |
1,075 |
$9K |
| 87081 |
|
658 |
641 |
$9K |
| 36561 |
|
14 |
12 |
$9K |
| 90685 |
|
4,552 |
4,528 |
$9K |
| J2800 |
Injection, methocarbamol, up to 10 ml |
578 |
384 |
$8K |
| 26720 |
|
57 |
56 |
$8K |
| 84112 |
|
210 |
202 |
$8K |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
922 |
645 |
$8K |
| 91065 |
|
57 |
54 |
$8K |
| 77001 |
|
231 |
219 |
$8K |
| 84520 |
|
1,794 |
1,737 |
$8K |
| 95819 |
|
49 |
49 |
$8K |
| 99383 |
|
72 |
71 |
$8K |
| 92588 |
|
90 |
90 |
$8K |
| 97164 |
|
384 |
380 |
$8K |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
453 |
252 |
$8K |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
72 |
69 |
$8K |
| 88360 |
|
67 |
65 |
$8K |
| 97598 |
|
195 |
107 |
$7K |
| M0239 |
Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring |
26 |
26 |
$7K |
| 99195 |
|
116 |
100 |
$7K |
| G2066 |
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results |
806 |
789 |
$7K |
| 92228 |
|
118 |
118 |
$7K |
| 11056 |
|
110 |
108 |
$7K |
| 64616 |
|
56 |
51 |
$7K |
| 92560 |
|
1,118 |
1,113 |
$7K |
| T1502 |
Administration of oral, intramuscular and/or subcutaneous medication by health care agency/professional, per visit |
2,394 |
2,047 |
$7K |
| 96138 |
|
336 |
330 |
$7K |
| 82947 |
|
1,069 |
1,051 |
$7K |
| 76519 |
|
163 |
160 |
$7K |
| T1016 |
Case management, each 15 minutes |
136,468 |
76,376 |
$7K |
| 76821 |
|
77 |
62 |
$7K |
| 82397 |
|
460 |
445 |
$7K |
| 26600 |
|
42 |
41 |
$6K |
| M0245 |
Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring |
19 |
19 |
$6K |
| L3807 |
Wrist hand finger orthosis, without joint(s), prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise |
88 |
87 |
$6K |
| 87328 |
|
328 |
317 |
$6K |
| J1580 |
Injection, garamycin, gentamicin, up to 80 mg |
1,591 |
1,455 |
$6K |
| J3111 |
Injection, romosozumab-aqqg, 1 mg |
12 |
12 |
$6K |
| 94626 |
|
124 |
39 |
$6K |
| 80195 |
|
331 |
272 |
$6K |
| 89220 |
|
194 |
191 |
$6K |
| H0038 |
Self-help/peer services, per 15 minutes |
277 |
233 |
$6K |
| 78306 |
|
25 |
25 |
$6K |
| 96368 |
|
243 |
181 |
$6K |
| 84681 |
|
193 |
191 |
$6K |
| 80178 |
|
558 |
521 |
$6K |
| 73720 |
|
14 |
12 |
$5K |
| 29105 |
|
62 |
61 |
$5K |
| J0574 |
Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine |
866 |
410 |
$5K |
| 73600 |
|
59 |
54 |
$5K |
| J1630 |
Injection, haloperidol, up to 5 mg |
1,434 |
1,302 |
$5K |
| J1940 |
Injection, furosemide, up to 20 mg |
1,618 |
1,069 |
$5K |
| 97010 |
|
608 |
408 |
$5K |
| 86880 |
|
553 |
528 |
$5K |
| 86036 |
|
739 |
719 |
$5K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
459 |
450 |
$5K |
| 92227 |
|
145 |
145 |
$5K |
| J0670 |
Injection, mepivacaine hydrochloride, per 10 ml |
1,080 |
1,049 |
$5K |
| 64644 |
|
25 |
25 |
$5K |
| 11719 |
|
111 |
111 |
$5K |
| M0247 |
Intravenous infusion, sotrovimab, includes infusion and post administration monitoring |
12 |
12 |
$5K |
| 90716 |
|
2,580 |
2,563 |
$5K |
| 92136 |
|
106 |
103 |
$5K |
| 72202 |
|
57 |
56 |
$5K |
| 93280 |
|
202 |
200 |
$5K |
| 77290 |
|
14 |
12 |
$5K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
171 |
109 |
$5K |
| 99201 |
|
209 |
205 |
$5K |
| 49450 |
|
13 |
13 |
$5K |
| 11101 |
|
77 |
75 |
$5K |
| 72114 |
|
47 |
46 |
$5K |
| 99384 |
|
43 |
41 |
$5K |
| 87906 |
|
45 |
44 |
$5K |
| 84157 |
|
821 |
746 |
$5K |
| 84590 |
|
273 |
268 |
$5K |
| 90621 |
|
614 |
613 |
$5K |
| 86352 |
|
25 |
24 |
$5K |
| 64405 |
|
29 |
25 |
$5K |
| 87517 |
|
119 |
118 |
$4K |
| 77075 |
|
28 |
27 |
$4K |
| 88377 |
|
15 |
12 |
$4K |
| 86593 |
|
1,107 |
1,087 |
$4K |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
3,860 |
1,975 |
$4K |
| 87329 |
|
364 |
355 |
$4K |
| 82945 |
|
707 |
649 |
$4K |
| 84425 |
|
282 |
277 |
$4K |
| 72131 |
|
26 |
25 |
$4K |
| 94668 |
|
100 |
77 |
$4K |
| 84155 |
|
1,313 |
1,190 |
$4K |
| 85240 |
|
142 |
130 |
$4K |
| 73070 |
|
57 |
51 |
$4K |
| 83498 |
|
137 |
129 |
$4K |
| 84446 |
|
297 |
291 |
$4K |
| 75635 |
|
12 |
12 |
$4K |
| 80156 |
|
180 |
174 |
$4K |
| J0613 |
Injection, calcium gluconate (wg critical care), not therapeutically equivalent to j0612, 10 mg |
309 |
180 |
$4K |
| 88311 |
|
515 |
485 |
$4K |
| 92556 |
|
68 |
68 |
$4K |
| 77076 |
|
39 |
39 |
$4K |
| 97032 |
|
110 |
74 |
$4K |
| 87900 |
|
40 |
38 |
$4K |
| 76512 |
|
52 |
49 |
$4K |
| 84132 |
|
515 |
466 |
$4K |
| J8540 |
Dexamethasone, oral, 0.25 mg |
1,950 |
1,475 |
$4K |
| 85520 |
|
157 |
95 |
$4K |
| G0381 |
Level 2 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) |
54 |
54 |
$3K |
| 85651 |
|
541 |
515 |
$3K |
| 51600 |
|
85 |
84 |
$3K |
| 74240 |
|
37 |
37 |
$3K |
| 82627 |
|
126 |
122 |
$3K |
| 80069 |
|
483 |
445 |
$3K |
| 82164 |
|
138 |
135 |
$3K |
| G0444 |
Annual depression screening, 5 to 15 minutes |
256 |
249 |
$3K |
| 80185 |
|
155 |
133 |
$3K |
| 85046 |
|
1,446 |
1,288 |
$3K |
| 90707 |
|
2,560 |
2,543 |
$3K |
| Q2039 |
Influenza virus vaccine, not otherwise specified |
214 |
214 |
$3K |
| 86381 |
|
226 |
223 |
$3K |
| 85045 |
|
510 |
418 |
$3K |
| 90846 |
Family psychotherapy without the patient present, 50 minutes |
18 |
13 |
$3K |
| G0123 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision |
117 |
114 |
$3K |
| 80230 |
|
189 |
181 |
$3K |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
371 |
282 |
$3K |
| 78264 |
|
13 |
12 |
$3K |
| 29345 |
|
13 |
12 |
$3K |
| D7140 |
Extraction, erupted tooth or exposed root |
14 |
13 |
$3K |
| 86015 |
|
416 |
409 |
$3K |
| 89050 |
|
629 |
554 |
$3K |
| 12053 |
|
12 |
12 |
$3K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
1,130 |
1,027 |
$3K |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
59 |
59 |
$3K |
| C2628 |
Catheter, occlusion |
42 |
40 |
$3K |
| 92520 |
|
38 |
38 |
$3K |
| 95910 |
|
38 |
38 |
$3K |
| 92225 |
|
70 |
69 |
$3K |
| J0744 |
Injection, ciprofloxacin for intravenous infusion, 200 mg |
371 |
296 |
$3K |
| 95873 |
|
40 |
38 |
$3K |
| 90636 |
|
44 |
44 |
$3K |
| 71271 |
|
28 |
28 |
$3K |
| 77081 |
|
271 |
260 |
$3K |
| 29126 |
|
48 |
46 |
$3K |
| 82340 |
|
272 |
263 |
$2K |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
2,677 |
2,015 |
$2K |
| 72220 |
|
40 |
40 |
$2K |
| P9040 |
Red blood cells, leukocytes reduced, irradiated, each unit |
18 |
14 |
$2K |
| J2400 |
Injection, chloroprocaine hydrochloride, per 30 ml |
132 |
126 |
$2K |
| 96381 |
|
148 |
147 |
$2K |
| 93926 |
|
27 |
26 |
$2K |
| 86148 |
|
84 |
83 |
$2K |
| 74170 |
|
12 |
12 |
$2K |
| 82104 |
|
138 |
136 |
$2K |
| 73620 |
|
32 |
27 |
$2K |
| J0885 |
Injection, epoetin alfa, (for non-esrd use), 1000 units |
31 |
12 |
$2K |
| 87899 |
|
95 |
93 |
$2K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
50 |
49 |
$2K |
| 76514 |
|
83 |
79 |
$2K |
| J0461 |
Injection, atropine sulfate, 0.01 mg |
378 |
296 |
$2K |
| 11720 |
|
56 |
56 |
$2K |
| 85245 |
|
43 |
38 |
$2K |
| 72080 |
|
26 |
26 |
$2K |
| 82952 |
|
821 |
815 |
$2K |
| 85004 |
|
276 |
264 |
$2K |
| 86141 |
|
111 |
110 |
$2K |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
512 |
488 |
$2K |
| J1805 |
Injection, esmolol hydrochloride, 10 mg |
307 |
280 |
$2K |
| 88172 |
|
75 |
65 |
$2K |
| A6211 |
Foam dressing, wound cover, sterile, pad size more than 48 sq. in., without adhesive border, each dressing |
31 |
27 |
$2K |
| 86341 |
|
82 |
80 |
$2K |
| 77280 |
|
12 |
12 |
$2K |
| J9250 |
Methotrexate sodium, 5 mg |
270 |
173 |
$2K |
| C1729 |
Catheter, drainage |
33 |
29 |
$2K |
| 76885 |
|
13 |
13 |
$2K |
| 95977 |
|
13 |
13 |
$2K |
| 93985 |
|
13 |
13 |
$2K |
| 27750 |
|
12 |
12 |
$2K |
| 84478 |
|
232 |
183 |
$2K |
| C1780 |
Lens, intraocular (new technology) |
1,480 |
1,347 |
$2K |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
421 |
407 |
$2K |
| 64612 |
|
14 |
14 |
$2K |
| 90632 |
|
29 |
29 |
$2K |
| 82310 |
|
264 |
246 |
$2K |
| 87184 |
|
77 |
72 |
$2K |
| 86008 |
|
13 |
13 |
$2K |
| 86645 |
|
76 |
74 |
$2K |
| 82232 |
|
144 |
127 |
$2K |
| 72192 |
|
12 |
12 |
$2K |
| 74220 |
|
24 |
24 |
$2K |
| C1781 |
Mesh (implantable) |
15 |
13 |
$2K |
| 86316 |
|
83 |
79 |
$1K |
| 86777 |
|
67 |
66 |
$1K |
| 12013 |
|
16 |
16 |
$1K |
| J1756 |
Injection, iron sucrose, 1 mg |
63 |
29 |
$1K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
155 |
150 |
$1K |
| 85130 |
|
132 |
129 |
$1K |
| L0984 |
Protective body sock, prefabricated, off-the-shelf, each |
27 |
12 |
$1K |
| 95909 |
|
25 |
25 |
$1K |
| 96136 |
|
65 |
65 |
$1K |
| 99407 |
|
95 |
92 |
$1K |
| J9000 |
Injection, doxorubicin hydrochloride, 10 mg |
46 |
26 |
$1K |
| 87088 |
|
190 |
184 |
$1K |
| 73503 |
|
12 |
12 |
$1K |
| 82024 |
|
40 |
39 |
$1K |
| 82274 |
|
82 |
79 |
$1K |
| J2598 |
Injection, vasopressin, 1 unit |
91 |
82 |
$1K |
| 88302 |
|
56 |
55 |
$1K |
| 80145 |
|
55 |
52 |
$1K |
| 95874 |
|
42 |
39 |
$1K |
| J0610 |
Injection, calcium gluconate (fresenius kabi), per 10 ml |
98 |
64 |
$1K |
| 0296T |
|
28 |
27 |
$1K |
| 99156 |
|
25 |
25 |
$1K |
| 88740 |
|
103 |
103 |
$1K |
| Q9968 |
Injection, non-radioactive, non-contrast, visualization adjunct (e.g., methylene blue, isosulfan blue), 1 mg |
12 |
12 |
$1K |
| 95012 |
|
28 |
28 |
$1K |
| A4315 |
Insertion tray with drainage bag with indwelling catheter, foley type, two-way, all silicone |
43 |
43 |
$1K |
| 76604 |
|
13 |
13 |
$1K |
| 86644 |
|
49 |
49 |
$1K |
| 88237 |
|
13 |
13 |
$1K |
| 83020 |
|
46 |
41 |
$1K |
| 82103 |
|
63 |
63 |
$1K |
| 87176 |
|
171 |
158 |
$987.53 |
| 84075 |
|
176 |
172 |
$981.28 |
| 17250 |
|
50 |
41 |
$962.99 |
| 90700 |
|
809 |
803 |
$918.18 |
| 90648 |
|
3,074 |
3,065 |
$903.04 |
| 97018 |
|
50 |
32 |
$884.68 |
| 99151 |
|
41 |
40 |
$880.30 |
| J7999 |
Compounded drug, not otherwise classified |
40 |
38 |
$859.96 |
| J0692 |
Injection, cefepime hydrochloride, 500 mg |
64 |
45 |
$842.78 |
| 0141U |
|
104 |
101 |
$839.02 |
| 74270 |
|
12 |
12 |
$830.83 |
| 86696 |
|
28 |
24 |
$804.09 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
134 |
133 |
$791.03 |
| 80183 |
|
90 |
87 |
$784.31 |
| J9260 |
Injection, methotrexate sodium, 50 mg |
57 |
37 |
$774.34 |
| 46600 |
|
12 |
12 |
$748.57 |
| 88350 |
|
12 |
12 |
$746.44 |
| 77012 |
|
12 |
12 |
$724.71 |
| J2471 |
Injection, pantoprazole (hikma), not therapeutically equivalent to j2470, 40 mg |
185 |
128 |
$718.63 |
| A9541 |
Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries |
16 |
15 |
$699.36 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
247 |
203 |
$698.67 |
| 84300 |
|
148 |
141 |
$694.15 |
| J1720 |
Injection, hydrocortisone sodium succinate, up to 100 mg |
132 |
99 |
$687.72 |
| 91200 |
|
41 |
41 |
$685.64 |
| 0552T |
|
14 |
14 |
$682.89 |
| 77002 |
|
38 |
37 |
$620.91 |
| 82955 |
|
44 |
44 |
$617.04 |
| Q5106 |
Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units |
23 |
13 |
$590.22 |
| 86663 |
|
28 |
28 |
$574.06 |
| 95908 |
|
13 |
13 |
$570.40 |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
12 |
12 |
$566.10 |
| J1836 |
Injection, metronidazole, 10 mg |
74 |
58 |
$566.08 |
| 92082 |
|
16 |
16 |
$549.41 |
| 82365 |
|
27 |
27 |
$549.14 |
| 86695 |
|
28 |
24 |
$526.42 |
| 93298 |
|
98 |
97 |
$522.26 |
| 84244 |
|
25 |
24 |
$505.52 |
| 86308 |
|
52 |
51 |
$504.15 |
| Q0177 |
Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
395 |
302 |
$486.35 |
| 86337 |
|
26 |
25 |
$464.74 |
| 77417 |
|
41 |
28 |
$447.50 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
204 |
181 |
$444.34 |
| 84154 |
|
25 |
25 |
$441.49 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
12,846 |
11,687 |
$437.20 |
| J9060 |
Injection, cisplatin, powder or solution, 10 mg |
33 |
12 |
$433.83 |
| 96137 |
|
13 |
13 |
$432.25 |
| 92060 |
|
15 |
15 |
$431.01 |
| G0380 |
Level 1 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) |
12 |
12 |
$423.73 |
| 88346 |
|
12 |
12 |
$416.63 |
| 86618 |
|
13 |
13 |
$408.18 |
| 86664 |
|
16 |
16 |
$403.38 |
| 80203 |
|
52 |
51 |
$387.22 |
| 82139 |
|
12 |
12 |
$363.22 |
| S0280 |
Medical home program, comprehensive care coordination and planning, initial plan |
9,124 |
7,979 |
$348.01 |
| 80202 |
|
19 |
12 |
$343.81 |
| 83921 |
|
14 |
14 |
$339.58 |
| 86580 |
|
36 |
35 |
$338.64 |
| 88142 |
|
12 |
12 |
$337.87 |
| 82465 |
|
53 |
38 |
$331.17 |
| 86705 |
|
26 |
26 |
$328.11 |
| 80235 |
|
26 |
26 |
$320.13 |
| 86735 |
|
28 |
27 |
$307.67 |
| 82525 |
|
25 |
25 |
$304.95 |
| 92020 |
|
14 |
13 |
$303.67 |
| 80201 |
|
13 |
12 |
$301.65 |
| 83010 |
|
16 |
15 |
$281.17 |
| 88331 |
|
15 |
12 |
$280.31 |
| 82653 |
|
24 |
24 |
$276.88 |
| 84144 |
|
12 |
12 |
$272.89 |
| J1626 |
Injection, granisetron hydrochloride, 100 mcg |
43 |
43 |
$265.82 |
| 82375 |
|
12 |
12 |
$265.28 |
| 90698 |
|
6,827 |
6,784 |
$263.05 |
| Q9958 |
High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml |
28 |
28 |
$244.96 |
| 97016 |
|
25 |
14 |
$239.41 |
| J0173 |
Injection, epinephrine (belcher), not therapeutically equivalent to j0171, 0.1 mg |
92 |
84 |
$230.80 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
31 |
30 |
$218.49 |
| 86060 |
|
17 |
17 |
$215.86 |
| 83006 |
|
56 |
55 |
$197.41 |
| A9503 |
Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries |
12 |
12 |
$186.82 |
| 83937 |
|
12 |
12 |
$180.60 |
| 82523 |
|
32 |
32 |
$165.70 |
| 90713 |
|
84 |
83 |
$157.68 |
| 82962 |
|
42 |
42 |
$148.80 |
| 82010 |
|
12 |
12 |
$144.98 |
| 86765 |
|
13 |
12 |
$141.06 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
42 |
40 |
$138.46 |
| 87147 |
|
14 |
13 |
$131.27 |
| 90633 |
|
5,346 |
5,315 |
$119.27 |
| 98960 |
|
12 |
12 |
$118.80 |
| 90744 |
|
3,017 |
2,979 |
$107.18 |
| A6260 |
Wound cleansers, any type, any size |
13 |
12 |
$97.26 |
| 83930 |
|
12 |
12 |
$83.77 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
360 |
345 |
$80.00 |
| J3430 |
Injection, phytonadione (vitamin k), per 1 mg |
16 |
16 |
$79.98 |
| 84133 |
|
18 |
17 |
$76.57 |
| G0127 |
Trimming of dystrophic nails, any number |
27 |
27 |
$70.92 |
| J0290 |
Injection, ampicillin sodium, 500 mg |
28 |
25 |
$67.22 |
| J2720 |
Injection, protamine sulfate, per 10 mg |
15 |
15 |
$64.21 |
| 90696 |
|
2,085 |
2,079 |
$42.54 |
| Q9965 |
Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml |
13 |
13 |
$42.49 |
| 81015 |
|
16 |
15 |
$34.53 |
| 90680 |
|
6,636 |
6,610 |
$32.25 |
| G8987 |
Self care functional limitation, current status, at therapy episode outset and at reporting intervals |
130 |
121 |
$28.06 |
| V2632 |
Posterior chamber intraocular lens |
250 |
226 |
$19.33 |
| 90723 |
|
2,655 |
2,647 |
$0.97 |
| 90710 |
|
2,396 |
2,389 |
$0.86 |
| 90647 |
|
44 |
44 |
$0.04 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
339 |
324 |
$0.00 |
| J2590 |
Injection, oxytocin, up to 10 units |
32 |
28 |
$0.00 |
| 90681 |
|
14 |
14 |
$0.00 |
| 0159T |
|
13 |
13 |
$0.00 |
| T2030 |
Assisted living, waiver; per month |
48 |
48 |
$0.00 |
| G8985 |
Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
24 |
24 |
$0.00 |
| G8988 |
Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
99 |
92 |
$0.00 |